InteRNA Technologies B.V.

InteRNA Technologies Announces Establishment of Scientific Advisory Board

InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways

UTRECHT, the Netherlands, July 8, 2010 - InteRNA Technologies B.V., a biopharmaceutical company focusing on the development of intelligent microRNA (miRNA)-based therapeutics for cancer, announces the establishment of its Scientific Advisory Board (SAB).

MORE..

Older News

UTRECHT, The Netherlands - InteRNA Technologies B.V.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy